Pruritus-Market Insight Epidemiology and Market Forecast-2027
Pruritus Report added by Reportsweb to its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, September 05, 2018 ) 'Pruritus in Atopic Dermatitis-Market Insights, Epidemiology and Market Forecast-2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Pruritus in Atopic Dermatitis in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.
The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Atopic Dermatitis as well as Pruritus in Atopic Dermatitis from 2016 to 2027 segmented by seven major markets. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.
Get Sample Copy of the Report: http://www.reportsweb.com/inquiry&RW00011660534/sample
The Pruritus in Atopic Dermatitis epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders.
The disease epidemiology covered in the report is segmented by prevalent population of Atopic Dermatitis, Atopic Dermatitis by Severity [mild, moderate & severe], AD by Pruritus burden, AD by Pruritus Severity [Moderate to Severe], Uncontrolled Atopic Dermatitis [Children & Adults] in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2027.
According to Publisher, the prevalent population of Pruritus in Atopic Dermatitis in 7 major markets was estimated to be 20.58 Million [7MM] in 2016 and, is expected to increase with a significant growth rate from 2016-2027. United States accounts for the highest Cases, followed by EU5 (Germany, France, Italy, Spain & UK) and Japan. Among EU5, Germany has been reported to have the highest prevalent population of pruritus in atopic dermatitis.
Table of Contents
1. Report Introduction
2. Pruritus in Atopic Dermatitis Market Overview at a Glance
2.1. Market Share Distribution of Pruritus in Atopic Dermatitis in 2017
2.2. Market Share Distribution of Pruritus in Atopic Dermatitis in 2027
3. Disease Background and Overview
3.1. Etiology
3.2. Risk Factors
3.3. Pathophysiology
3.3.1. Mediators involved in Pathophysiology
3.3.2. Major Mediators for inducing Pruritus in atopic Dermatitis
3.3.3. Emphasis on development of Phosphodiesterase-4 inhibitors
3.3.4. Other Mediators
3.3.5. Potential targets for antipruritic therapy in AD
3.3.6. Triggering factors involved in pathophysiology
3.4. Diagnosis
3.4.1. American Academy of Dermatology Diagnostic Criteria
3.4.2. United Kingdom Working Party Diagnostic criteria
3.4.3. Japanese Dermatological Association Diagnostic Criteria
4. Epidemiology and Patient Population
4.1. Disease Definition
4.2. Population and Forecast Parameters
4.3. Population Methods
4.3.1. Total prevalent cases in the US
4.3.2. EU5
4.3.3. Japan
4.4. Prevalent Population of Atopic Dermatitis in 7MM
4.5. Prevalent Population of Atopic Dermatitis by Severity in 7MM
4.6. Prevalent Cases of Atopic Dermatitis by Pruritus Burden in 7MM
4.6.1. Prevalent Cases of Atopic Dermatitis by Pruritus Burden in the United States
4.6.2. Prevalent Cases of Atopic Dermatitis by Pruritus Burden in Germany
4.6.3. Prevalent Cases of Atopic Dermatitis by Pruritus Burden in France
4.6.4. Prevalent Cases of Atopic Dermatitis by Pruritus Burden in Italy
Place Direct Purchase order For Complete report @ http://www.reportsweb.com/inquiry&RW00011660534/discount
The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Atopic Dermatitis as well as Pruritus in Atopic Dermatitis from 2016 to 2027 segmented by seven major markets. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.
Get Sample Copy of the Report: http://www.reportsweb.com/inquiry&RW00011660534/sample
The Pruritus in Atopic Dermatitis epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders.
The disease epidemiology covered in the report is segmented by prevalent population of Atopic Dermatitis, Atopic Dermatitis by Severity [mild, moderate & severe], AD by Pruritus burden, AD by Pruritus Severity [Moderate to Severe], Uncontrolled Atopic Dermatitis [Children & Adults] in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2027.
According to Publisher, the prevalent population of Pruritus in Atopic Dermatitis in 7 major markets was estimated to be 20.58 Million [7MM] in 2016 and, is expected to increase with a significant growth rate from 2016-2027. United States accounts for the highest Cases, followed by EU5 (Germany, France, Italy, Spain & UK) and Japan. Among EU5, Germany has been reported to have the highest prevalent population of pruritus in atopic dermatitis.
Table of Contents
1. Report Introduction
2. Pruritus in Atopic Dermatitis Market Overview at a Glance
2.1. Market Share Distribution of Pruritus in Atopic Dermatitis in 2017
2.2. Market Share Distribution of Pruritus in Atopic Dermatitis in 2027
3. Disease Background and Overview
3.1. Etiology
3.2. Risk Factors
3.3. Pathophysiology
3.3.1. Mediators involved in Pathophysiology
3.3.2. Major Mediators for inducing Pruritus in atopic Dermatitis
3.3.3. Emphasis on development of Phosphodiesterase-4 inhibitors
3.3.4. Other Mediators
3.3.5. Potential targets for antipruritic therapy in AD
3.3.6. Triggering factors involved in pathophysiology
3.4. Diagnosis
3.4.1. American Academy of Dermatology Diagnostic Criteria
3.4.2. United Kingdom Working Party Diagnostic criteria
3.4.3. Japanese Dermatological Association Diagnostic Criteria
4. Epidemiology and Patient Population
4.1. Disease Definition
4.2. Population and Forecast Parameters
4.3. Population Methods
4.3.1. Total prevalent cases in the US
4.3.2. EU5
4.3.3. Japan
4.4. Prevalent Population of Atopic Dermatitis in 7MM
4.5. Prevalent Population of Atopic Dermatitis by Severity in 7MM
4.6. Prevalent Cases of Atopic Dermatitis by Pruritus Burden in 7MM
4.6.1. Prevalent Cases of Atopic Dermatitis by Pruritus Burden in the United States
4.6.2. Prevalent Cases of Atopic Dermatitis by Pruritus Burden in Germany
4.6.3. Prevalent Cases of Atopic Dermatitis by Pruritus Burden in France
4.6.4. Prevalent Cases of Atopic Dermatitis by Pruritus Burden in Italy
Place Direct Purchase order For Complete report @ http://www.reportsweb.com/inquiry&RW00011660534/discount
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results